EURACTIV - Belgium's health minister, Frank Vandenbroucke, has outlined the federal government's 2026 health policy priorities before the Commission on Health and Equal Opportunities, placing long‑awaited reforms to ethics committees formally on the legislative agenda. The move marks the transition from the broad commitments set out in the...

EU PERSPECTIVES - Europe is testing plenty of new medicines—but mostly at the later stages. The earliest, most experimental studies, where drugs are first tried in humans, remain surprisingly scarce. According to Dr Peter Arlett of the European Medicines Agency (EMA), this imbalance could shape the future of medical innovation in the EU. Read more

EUROPEAN BIOTECHNOLOGY MAGAZINE - Europe produces world-class life sciences research, yet still struggles to finance and scale it. Venture capital in European biotech accounts for just 7 per cent of global funding, while 66 of the 67 EU biotech companies that went public over the past six years chose to list outside Europe. Capital is available...

EU PERSPECTIVES - As Cyprus uses its EU Council presidency to push mental health higher up the bloc's agenda, Luxembourg has stepped forward as one of the first member states to publicly back the initiative. Martine Deprez, Luxembourg's health minister, tells EU Perspectives about the reasons behind the move. Read more

EURACTIV - As the EU debates competitiveness, innovation and strategic autonomy, a growing share of young Europeans say they are not being heard in the decisions shaping their future. Read more

EUROPEAN BIOTECHNOLOGY MAGAZINE - After more than a decade of failed drug development efforts, osteoarthritis remains one of biopharma's most stubborn challenges. Despite affecting more than 600 million people worldwide, no therapy approved in Europe or the United States has yet been shown to slow or modify disease progression. Against...

EU PERSPECTIVES - Medicine supply talks are under way and budget decisions loom not far ahead. Those are the first stress tests Europe's health autonomy agenda faces under the six-month Cypriot presidency of the Council of the European Union. Read more

EU PERSPECTIVES - Poor countries lacking access to treatment report over 70 per cent of cancer deaths. Europe, home to ten per cent of global population, registers a quarter of cancer cases. Ulrika Årehed Kågström, president of the Union of International Cancer Control (UICC), spoke to EU Perspectives about the challenges of fighting cancer on both...

EURACTIV - Cancer innovation is advancing at unprecedented speed, but Belgium's access systems are struggling to keep up, risking delays in patient access to personalised, biomarker-driven treatments, according to Koen Van Impe (KVI), CEO of the Belgian Cancer Foundation. Read more

EURACTIV - Decisions in Brussels are increasingly shaped earlier, faster and more politically than the formal legislative process suggests. For anyone trying to influence EU policy, the old playbook no longer works. Read more